149 related articles for article (PubMed ID: 32570243)
1. Comparison of Clinicopathological Features of Biliary Neuroendocrine Carcinoma with Adenocarcinoma.
Shiihara M; Higuchi R; Furukawa T; Yazawa T; Uemura S; Izumo W; Yamamoto M
Dig Surg; 2021; 38(1):30-37. PubMed ID: 32570243
[TBL] [Abstract][Full Text] [Related]
2. Mixed adenoneuroendocrine carcinoma of the extrahepatic bile duct: a case report.
Zhang HW; Kou K; Qi J; Xie EB; Wang M; Li Y; Lv GY; Wang GY
J Int Med Res; 2019 Jul; 47(7):3421-3426. PubMed ID: 31154920
[TBL] [Abstract][Full Text] [Related]
3. Mixed neuroendocrine-non-neuroendocrine neoplasm with mucinous adenocarcinoma and amphicrine carcinoma components in the bile duct: an autopsy case.
Murabayashi T; Kanno Y; Odaira T; Koshita S; Ogawa T; Kusunose H; Sakai T; Yonamine K; Miyamoto K; Kozakai F; Endo K; Noda Y; Sawai T; Ito K
Clin J Gastroenterol; 2023 Apr; 16(2):310-316. PubMed ID: 36689097
[TBL] [Abstract][Full Text] [Related]
4. Mixed adenoneuroendocrine carcinoma of the hepatic bile duct: a case report and review of the literature.
Liu S; Zhong Z; Xiao M; Song Y; Zhu Y; Hu B; Sun Z; Yi W; Peng C
BMC Gastroenterol; 2020 Nov; 20(1):399. PubMed ID: 33238879
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic study of mixed adenoneuroendocrine carcinomas of hepatobiliary organs.
Harada K; Sato Y; Ikeda H; Maylee H; Igarashi S; Okamura A; Masuda S; Nakanuma Y
Virchows Arch; 2012 Mar; 460(3):281-9. PubMed ID: 22358181
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for survival after curative resection of gastric mixed adenoneuroendocrine carcinoma: a series of 80 patients.
Xie JW; Lu J; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Zheng CH; Li P; Huang CM
BMC Cancer; 2018 Oct; 18(1):1021. PubMed ID: 30348122
[TBL] [Abstract][Full Text] [Related]
7. A case report of primary neuroendocrine carcinoma of the perihilar bile duct.
Kihara Y; Yokomizo H; Urata T; Nagamine M; Hirata T
BMC Surg; 2015 Dec; 15():125. PubMed ID: 26652845
[TBL] [Abstract][Full Text] [Related]
8. Intrahepatic bile duct mixed adenoneuroendocrine carcinoma: a case report and review of the literature.
Zheng SL; Yip VS; Pedica F; Prachalias A; Quaglia A
Diagn Pathol; 2015 Nov; 10():204. PubMed ID: 26589730
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative frozen section diagnosis of bile duct margin for extrahepatic cholangiocarcinoma.
Shiraki T; Kuroda H; Takada A; Nakazato Y; Kubota K; Imai Y
World J Gastroenterol; 2018 Mar; 24(12):1332-1342. PubMed ID: 29599608
[TBL] [Abstract][Full Text] [Related]
10. Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma.
Sasaki R; Takeda Y; Funato O; Nitta H; Kawamura H; Uesugi N; Sugai T; Wakabayashi G; Ohkohchi N
World J Surg; 2007 Sep; 31(9):1788-1796. PubMed ID: 17647056
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma.
Lim SM; Kim H; Kang B; Kim HS; Rha SY; Noh SH; Hyung WJ; Cheong JH; Kim HI; Chung HC; Yun M; Cho A; Jung M
Ann Nucl Med; 2016 May; 30(4):279-86. PubMed ID: 26837515
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive genetic features of gastric mixed adenoneuroendocrine carcinomas and pure neuroendocrine carcinomas.
Koh J; Nam SK; Kwak Y; Kim G; Kim KK; Lee BC; Ahn SH; Park DJ; Kim HH; Park KU; Kim WH; Lee HS
J Pathol; 2021 Jan; 253(1):94-105. PubMed ID: 32985687
[TBL] [Abstract][Full Text] [Related]
13. [Pre-surgical diagnosis of neuroendocrine carcinoma of the extrahepatic bile duct: a case study].
Tajima M; Nishikawa T; Shirouzu M; Hayakawa S; Yanagisawa N; Nagura A; Sakakibara S; Kojima I; Nonogaki K
Nihon Shokakibyo Gakkai Zasshi; 2023; 120(1):96-103. PubMed ID: 36631122
[TBL] [Abstract][Full Text] [Related]
14. The clinical significance of preoperative C-reactive protein/albumin ratio in patients with resected extrahepatic bile duct cancer.
Song DH; Cho IK; Shin DW; Lee JC; Cho JY; Yoon YS; Hwang JH; Han HS; Kim J
Surg Today; 2021 Jun; 51(6):978-985. PubMed ID: 33387024
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Impact of the Initial Postoperative CA19-9 Level in Patients with Extrahepatic Bile Duct Cancer.
Kato Y; Takahashi S; Gotohda N; Konishi M
J Gastrointest Surg; 2016 Aug; 20(8):1435-43. PubMed ID: 27250990
[TBL] [Abstract][Full Text] [Related]
16. Comparison of overall survival of gastric neoplasms containing neuroendocrine carcinoma components with gastric adenocarcinoma: a propensity score matching study.
Chen J; Wang A; Ji K; Bu Z; Ji J
BMC Cancer; 2020 Aug; 20(1):777. PubMed ID: 32811471
[TBL] [Abstract][Full Text] [Related]
17. Management of resectable esophageal and gastric (mixed adeno)neuroendocrine carcinoma: A nationwide cohort study.
van der Veen A; Seesing MFJ; Wijnhoven BPL; de Steur WO; van Berge Henegouwen MI; Rosman C; van Sandick JW; Mook S; Haj Mohammad N; Ruurda JP; Brosens LAA; van Hillegersberg R;
Eur J Surg Oncol; 2018 Dec; 44(12):1955-1962. PubMed ID: 30201419
[TBL] [Abstract][Full Text] [Related]
18. Surgery for recurrent biliary carcinoma: results for 27 recurrent cases.
Noji T; Tsuchikawa T; Mizota T; Okamura K; Nakamura T; Tamoto E; Shichinohe T; Hirano S
World J Surg Oncol; 2015 Feb; 13():82. PubMed ID: 25884694
[TBL] [Abstract][Full Text] [Related]
19. Carcinoma of the extrahepatic bile duct: mode of spread and its prognostic implications.
Yamaguchi K; Chijiiwa K; Saiki S; Shimizu S; Takashima M; Tanaka M
Hepatogastroenterology; 1997; 44(17):1256-61. PubMed ID: 9356836
[TBL] [Abstract][Full Text] [Related]
20. Small-cell Neuroendocrine Carcinoma of the Extrahepatic Bile Duct: A Rare Case Report.
Han B; Seo YJ; Oh GH; You GR; Ma KY; Kim KH; Noh MG; Joo YE
Korean J Gastroenterol; 2023 Mar; 81(3):121-124. PubMed ID: 36960694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
